Department of Physical Education, Korea University, Seoul, Republic of Korea.
Department of Sports Medicine and Sports Nutrition, Faculty of Sport Science, Ruhr-University Bochum, Gesundheitscampus Nord, Haus 10, 44801, Bochum, Germany.
BMC Womens Health. 2022 May 10;22(1):150. doi: 10.1186/s12905-022-01740-y.
It is suspected that hormonal fluctuations during menstruation may cause different responses to strength training in women who use oral contraceptives (OC) versus those who do not. However, previous studies that investigated the existence of such differences produced conflicting results. In this study, we hypothesized that OC use has no effect on muscle strength and hypertrophy among women undergoing strength training. Thus, we compared the differences in muscle strength and thickness among women who used OCs and those who did not.
We investigated the influence of OC use on muscle strength (F), muscle thickness (Mtk), type 1-to-type 2 muscle fiber (NO) ratio, muscle fiber thickness (MFT), and nuclear-to-fiber (N/F) ratio. Seventy-four healthy young women (including 34 who used OCs and 40 who did not) underwent 12 weeks of submaximal strength training, after which F was evaluated using a leg-press machine with a combined force and load cell, while Mtk was measured using real-time ultrasonography. Moreover, the NO ratio, MFT, and N/F ratio were evaluated using muscle needle biopsies.
Participants in the non-OC and OC groups experienced increases in F (+ 23.30 ± 10.82 kg and + 28.02 ± 11.50 kg respectively, p = 0.073), Mtk (+ 0.48 ± 0.47 cm and + 0.50 ± 0.44 cm respectively, p = 0.888), F/Mtk (+ 2.78 ± 1.93 kg/cm and + 3.32 ± 2.37 kg/cm respectively, p = 0.285), NO ratio (type 2 fibers: + 1.86 ± 6.49% and - 4.17 ± 9.48% respectively, p = 0.169), MFT (type 2 fibers: + 7.15 ± 7.50 µm and + 4.07 ± 9.30 µm respectively, p = 0.435), and N/F ratio (+ 0.61 ± 1.02 and + 0.15 ± 0.97 respectively, p = 0.866) after training. There were no significant differences between the non-OC and OC groups in any of these parameters (p > 0.05).
The effects of 12 weeks of strength training on F, muscle thickness, muscle fiber size, and composition were similar in young women irrespective of their OC use.
据推测,月经期间的激素波动可能导致使用口服避孕药(OC)和不使用 OC 的女性对力量训练的反应不同。然而,之前研究这些差异存在的研究得出了相互矛盾的结果。在这项研究中,我们假设 OC 使用不会影响接受力量训练的女性的肌肉力量和肥大。因此,我们比较了使用 OC 和不使用 OC 的女性之间的肌肉力量和厚度差异。
我们研究了 OC 使用对肌肉力量(F)、肌肉厚度(Mtk)、1 型到 2 型肌纤维(NO)比、肌纤维厚度(MFT)和核与纤维(N/F)比的影响。74 名健康年轻女性(包括 34 名使用 OC 和 40 名未使用 OC)接受了 12 周的亚最大强度训练,之后使用带有组合力和负载单元的腿部按压机评估 F,同时使用实时超声测量 Mtk。此外,使用肌肉针活检评估 NO 比、MFT 和 N/F 比。
非 OC 和 OC 组的参与者的 F 增加(分别为+23.30±10.82 kg 和+28.02±11.50 kg,p=0.073),Mtk 增加(分别为+0.48±0.47 cm 和+0.50±0.44 cm,p=0.888),F/Mtk 增加(分别为+2.78±1.93 kg/cm 和+3.32±2.37 kg/cm,p=0.285),NO 比(2 型纤维:分别为+1.86±6.49%和-4.17±9.48%,p=0.169),MFT(2 型纤维:分别为+7.15±7.50 µm 和+4.07±9.30 µm,p=0.435)和 N/F 比(分别为+0.61±1.02 和+0.15±0.97,p=0.866)。训练后,非 OC 和 OC 组之间在任何参数上均无显著差异(p>0.05)。
12 周的力量训练对 F、肌肉厚度、肌纤维大小和组成的影响在年轻女性中相似,无论她们是否使用 OC。